Translabyrinthine removal of large acoustic neuromas.
Several surgical approaches to the cerebellopontine angle and internal auditory canal have been developed for the removal of acoustic neuromas. The choice of an approach may be influenced by hearing levels and tumor size. We reviewed the records of the primary translabyrinthine removal of 167 large (> or = 4 cm) acoustic neuromas performed between 1982 and 1990. Patients ranged in age from 15 to 83 years, with a mean of 43 years (male, 49%; female, 51%). Total removal was achieved in 95%. The facial nerve was preserved anatomically intact in 91%. At follow-up (mean, 2.1 yr), facial nerve function was acceptable (Grades I-IV) in 75% and good (Grades I-II) in 42%. Vascular complications occurred in 4.8%; however, there were no deaths. A cerebrospinal fluid leak occurred in 9.6% of cases, and meningitis occurred in 8.3%. In patients with large tumors where there is little chance to preserve preoperative hearing, we have successfully used the translabyrinthine approach for total tumor removal. The advantages and disadvantages of both the translabyrinthine and suboccipital approaches are discussed.
Briggs
R J
RJ
House Ear Clinic, Los Angeles, California.
Luxford
W M
WM
Atkins
J S
JS
Hitselberger
W E
WE
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001301:Audiometry, Pure-Tone; D001763:Blepharoptosis / Q000175:diagnosis / Q000209:etiology; D002524:Cerebellar Ataxia / Q000175:diagnosis / Q000209:etiology; D003389:Cranial Nerve Diseases / Q000175:diagnosis / Q000209:etiology; D020209:Cranial Nerve Injuries; D007758:Ear, Inner / Q000601:surgery*; D005154:Facial Nerve / Q000601:surgery; D005158:Facial Paralysis / Q000175:diagnosis / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008866:Microsurgery; D008875:Middle Aged; D009460:Neurologic Examination; D009464:Neuroma, Acoustic / Q000175:diagnosis / Q000601:surgery*; D010211:Papilledema / Q000175:diagnosis / Q000209:etiology; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology*; D012189:Retrospective Studies; D013063:Speech Discrimination Tests; D016896:Treatment Outcome